Chris Nolet - Jun 18, 2025 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Role
Director
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact for Chris Nolet
Stock symbol
AVBP
Transactions as of
Jun 18, 2025
Transactions value $
$0
Form type
4
Date filed
6/20/2025, 07:29 PM
Previous filing
Feb 6, 2025
Next filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nolet Chris Director C/O ARRIVENT BIOPHARMA, INC., 18 CAMPUS BOULEVARD SUITE 100, NEWTOWN SQUARE By: /s/ James Kastenmayer, Attorney-in-Fact for Chris Nolet 2025-06-20 0001782814

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Non-Qualified Stock Option (right to buy) Award $0 +15.5K $0.00 15.5K Jun 18, 2025 Common Stock 15.5K $24.89 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.